Parties will establish a Center of Excellence in CMIC’s NJ plant.
CMIC CMO USA Corporation, a subsidiary of contract development and manufacturing organization (CDMO), CMIC CMO Co., Ltd., and Rutgers University, are partnering up to further grow the advanced pharmaceutical manufacturing field. Specifically, the parties have agreed to join forces to establish a Center of Excellence in advanced pharmaceutical manufacturing, co-located at CMIC’s 224,000 square-foot facility in New Jersey.
Since 2006, the Rutgers School of Engineering has been a pharmaceutical research contributor through the Center for Structured Organic Particulate Systems (C-SOPS). C-SOPS has assembled a cross-disciplinary team of researchers from major universities, working in close collaboration with industry leaders and regulatory authorities to improve pharmaceutical, food, and agricultural product manufacturing methods.
“We are very excited about this partnership. CMIC and Rutgers’ shared commitment to innovation and excellence fully aligns with our vision,” says Makoto Matsukawa, CEO of CMIC CMO. “Together, we can enhance pharmaceutical manufacturing technologies and processes, contributing to the industry’s global advancement.”
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.
Social Media's Influence on Young Women's Reproductive Decisions
February 20th 2025In this Q&A, Organon's Chief Communications Officer, Becky Edwards discusses how much social media and influencers sway decisions about birth control methods, potential consequences of these misinformed choices, and more.